We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

22 hedge funds and large institutions have $43.7M invested in Tonix Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

22% more funds holding

Funds holding: 18 → 22 (+4)

0% more ownership

Funds ownership: 0% → 0% (+0%)

15% less capital invested

Capital invested by funds: $51.2M → $43.7M (-$7.5M)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.04M
2
Prudential Financial
Prudential Financial
New Jersey
+$3.18M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.54M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.91M
5
BlackRock
BlackRock
New York
+$1.59M

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$325K
2
Citadel Advisors
Citadel Advisors
Florida
-$318K
3
Deutsche Bank
Deutsche Bank
Germany
-$318K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$318K
5
VF
Virtu Financial
New York
-$318K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$84K – – –
Wells Fargo
27
Wells Fargo
California
$79K – – –
Citadel Advisors
28
Citadel Advisors
Florida
$78K -$318K -1 Closed
JP Morgan Chase
29
JP Morgan Chase
New York
$74K – – –
AllianceBernstein
30
AllianceBernstein
Tennessee
$72K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$67K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$63K – – –
State Board of Administration of Florida Retirement System
33
State Board of Administration of Florida Retirement System
Florida
$63K – – –
ProShare Advisors
34
ProShare Advisors
Maryland
$57K – – –
SG Americas Securities
35
SG Americas Securities
New York
$56K – – –
EMG
36
ETF Managers Group
New Jersey
$48K – – –
Citigroup
37
Citigroup
New York
$46K – – –
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$45K – – –
VOYA Investment Management
39
VOYA Investment Management
Georgia
$44K – – –
Invesco
40
Invesco
Georgia
$42K – – –
EDRH
41
Edmond de Rothschild Holding
Switzerland
$36K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$34K – – –
Principal Financial Group
43
Principal Financial Group
Iowa
$29K – – –
SO
44
STRS Ohio
Ohio
$27K – – –
Victory Capital Management
45
Victory Capital Management
Texas
$26K – – –
CS
46
Credit Suisse
Switzerland
$22K – – –
AB
47
Amalgamated Bank
New York
$19K – – –
HF
48
HRT Financial
New York
$16K – – –
Legal & General Group
49
Legal & General Group
United Kingdom
$13K – – –
Osaic Holdings
50
Osaic Holdings
Arizona
$12K – – –
1
2
3 4

TNXP Hedge Fund Activity: Q4 2021 in Review

22 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2021, worth a combined $43.7M — down 15% from $51.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNXP positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $6.04M. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $325K sold.

  • 22 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2021, up from 18 in Q3 2021.
  • Funds reported $43.7M of Tonix Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
  • 8 funds opened new Tonix Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q4 2021 was D.E. Shaw & Co, an estimated $6.04M added.
  • The largest Tonix Pharmaceuticals seller in Q4 2021 was Qube Research & Technologies (QRT), an estimated $325K sold.

Based on aggregated 13F filings for Q4 2021.